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PEDIATRIC CARDIAC
SURGERY: EFFECT OF
A MINIATURIZED BYPASS
CIRCUIT IN REDUCING
HOMOLOGOUS BLOOD
TRANSFUSION
To the Editor:
I read with great interest the excel-
lent article by Koster and colleagues.1
We have recently published our expe-
rience in treating 150 pediatric patients
with a 120-mL prime volumeminiatur-
ized bypass circuit, vacuum-assisted
venous drainage, and intermittent
warm blood microplegia.2 Our results,
although less impressive than those of
Koster and colleagues,1 confirmed the
efficiency of a small prime volume
for reduction of allogeneic blood trans-
fusion. With a nadir hemoglobin value
of 8 g/dL during cardiopulmonary by-
pass, we demonstrated the good toler-
ance of hemodilution using 2
markers: preoperative and postopera-
tive lactate levels (which were lower
in patients undergoing bloodless sur-
gery than in transfused patients) and
time to extubation (which was shorter
in patients undergoing bloodless sur-
gery than in transfused patients). Our
major concern was to not counterbal-
ance the potential benefit of bloodless
surgery by altering the intraoperative
or postoperative care, thus inducing
other risks. We firmly believe that
transfusion cannot be the only out-
come end point in such a study group.
Pediatric perfusion is a challenging
technique with conflicting goals. The
benefit expected from reducing transfu-
sion requirements is a better immediate
outcome at a lower cost.3 On the other
hand, a too low hematocrit level is haz-
ardous, and less than23.5% is said to be
associated with lower Psychomotor
Development Index scores and in-
creased lactate levels.4 In the literature
the need for somenorepinephrinebolus,
increased inotropic support, increased
ventilation time, and increased length
of critical care or hospitalization stay
have all been related to low periopera-
tive hematocrit levels.
In Koster and colleagues’ study
group,1 the factor triggering blood
transfusion during surgical intervention
was clearly a hemoglobin value of less
than 7 g/dL. However, the triggering
factor was less clear for the 4 patients
transfused during the further course.
The rationale to tolerate the same nadir
level of 7 g/dL of hemoglobin during
surgical intervention in patients with
large differences in preoperative hemo-
globin levels (from 11.1 g/dL [the low-
est level in the study] to 16.0 g/dL [the
highest level in the study]) is not obvi-
ous. Similarly, the technique used to
reverse the intraoperative anemia and
reach the postoperative hemoglobin tar-
get values, namely 8 to 10 g/dL in pa-
tients with anatomic correction and 12
to 16 g/dL in cyanotic patients with pal-
liative procedures, is unclear.
Even if 85% of the patients were fi-
nally transfused, Koster and col-
leagues1 are to be congratulated for
their energy in promoting bloodless
neonatal surgery. The efficiency of
the miniaturized bypass circuit in re-
ducing blood transfusion is well estab-
lished. However, the link between
bloodless surgery and improved im-
mediate clinical outcome has yet to
be confirmed, as has its lack of harm
on late neurological outcome.
Yves Dominique Durandy, MD
Intensive Care Unit
Institut Jacques Cattier
Massy, France
References
1. Koster A, Huebler M, Boettcher W, Redlin M,
Berger F, Hetzer R. A new miniaturized cardiopul-
monary bypass system reduces transfusion require-
ments during neonatal cardiac surgery: initial
experience in 13 consecutive patients. J Thorac
Cardiovasc Surg. 2009;13:1565-8.
2. Durandy Y. The impact of vacuum-assisted venous
drainage and miniaturized bypass circuits on blood
transfusion in pediatric cardiac surgery. ASAIO J.
2009;55:117-22.
3. Hickey E, Karamlou T, You J, Ungerleider RM. Ef-
fects of circuit miniaturization in reducing inflam-
matory response to infant cardiopulmonary bypass
by elimination of allogeneic blood products. Ann
Thorac Surg. 2006;81:2367-72.
4. Wypij D, Jonas RA, Bellinger D, Del Nido PJ,
Mayer JE, Bacha EA, et al. The effect of hematocrit
during hypothermic cardiopulmonary bypass in in-
fant heart surgery: results from the combined Bos-
ton hematocrit trials. J Thorac Cardiovasc Surg.
2008;135:355-60.
doi:10.1016/j.jtcvs.2009.06.030
The Editor welcomes submissions for possible publica-
tion in the Letters to the Editor section that consist of
commentary on an article published in the Journal or
other relevant issues. Authors should:  Include no
more than 500 words of text, three authors, and
five references.  Type with double-spacing.  See
http://jics.ctsnetjournals.org/misc/ifora.shtml for de-
tailed submission instructions.  Submit the letter
electronically via jtcvs.editorialmanager.com. Let-
ters commenting on an article published in the
JTCVS will be considered if they are received
within 6 weeks of the time the article was
published. Authors of the article being commented
on will be given an opportunity of offer a timely
response (2 weeks) to the letter. Authors of letters
will be notified that the letter has been received.
Unpublished letters cannot be returned.
1454 The Journal of Thoracic and Cardiovascular Surgery c December 2
LETTERS TO THE EDITORReply to the Editor:
We thank Dr Durandy very much for
her comments. We completely agree
that performing transfusion-free sur-
gery cannot be a goal in itself. There
are convincing data from the adult
world and first data from the pediatric
world of cardiac surgery showing that
transfusion of allogeneic blood impairs
clinical outcomes. However, the small
scale of our investigation and the great
heterogeneity of cardiac malformations
meant that the studywas not powered to
perform an assessment in this regard.
As you outlined, in addition to the
technical aspects of the perfusion tech-
nique and the cardiopulmonary bypass
(CPB) setup, definition of the critical
hemoglobin value as a trigger for trans-
fusion remains a key question. As you
outlined, Jonas and coleagues1 re-
ported adverse neurological outcomes
in patients with a hematocrit level of
less than 20%, whereas a hematocrit
level of 24% was safe.2 In these pa-
tients surgical intervention was per-
formed during deep hypothermic
cardiac arrest or with low-flow CPB.
In our investigation only 6 patients un-
derwent deep hypothermia. However,
we performed regional arterial cerebral
perfusion and continuous measure-
ment of cerebral oxygenation using
near-infrared spectroscopy, which is
an established monitoring tool under
these circumstances.3,4 Therefore009
A NEW DIAGNOSTIC
ALGORITHM FOR
ASSESSMENT OF PATIENTS
WITH SINGLE VENTRICLE
BEFORE A FONTAN
OPERATION
To the Editor:
We read with interest the article of
Prakash and associates entitled ‘‘A
new diagnostic algorithm for assess-
ment of patients with single ventricle
before Fontan operation.’’1 We found
it appealing to spare these children in-
vasive and costly procedures in the era
of rampant health care costs. In their
retrospective study the authors devel-
oped an algorithm that identifies
high-risk patients for the completion
of partial cavopulmonary connection.
This algorithm is based on clinical
and noninvasive imaging criteria and
limits cardiac catheterization only to
high-risk patients.
We and others believe that the major
indication for cardiac catheterization
in patients with partial cavopulmonary
connection is to measure the pulmo-
nary arterial pressure. Left ventricular
function and pulmonary arterial pres-
sure are the 2 most important criteria
in identifying patients at risk for the
completion of the Fontan procedure.2
Should we assume that all patients
with normal pulmonary artery size
and normal ventricular function in
the absence of pulmonary branch ste-
nosis have acceptable levels of pulmo-
nary artery pressure?
Ba and colleagues3 found in their
report that clinical signs identified
only a minority of patients in whom
the Fontan procedure was contraindi-
cated and detected a subgroup of
patients with normal pulmonary ar-
tery size and high pulmonary artery
pressure.
To this day, Fontan-like procedures
are the only option for patients with
a single ventricle. If the completion
of a cavopulmonary connection is con-
traindicated, the patient is usually
scheduled for heart transplantation.
On the other hand, failure of the total
cavopulmonary connection or its take-
down is usually followed by a stormy
postoperative course and a high mor-
tality rate. Hence we believe that the
decision to proceed to a total cavopul-
monary connection is extremely deli-
cate; cardiac catheterization remains
the gold standard for the contraindica-
tion of a total cavopulmonary connec-
tion until comparative prospective
Letters to the Editorunder these controlled conditions, we
consider a hemoglobin value of greater
than 7 g/dL (hematocrit level,>21%)
to be safe. However, as you can see in
Figure 2 of our article, only 1 patient
had a hemoglobin value of less than 8
g/dL (hematocrit level, 24%).
During CPB, we defined the critical
hemoglobin value as 7 g/dL, regardless
of the preoperative hemoglobin value
and regardless of the cardiac malforma-
tion of the patient. The target hemoglo-
bin values after CPB depended on
whether (near-) anatomic correction
with physiologic perfusion of the lungs
was achieved (critical hemoglobin
value, 8–10 g/dL) or only palliation
(critical hemoglobin value, 12–16 g/
dL) was established. The higher target
hemoglobin value of 12 to 16 g/dL
was responsible for the observation
that all patientswith cyanoticmalforma-
tions and nonanatomic correction of
lung perfusion had to receive transfu-
sion before termination of CPB or dur-
ing the further course. In contrast, in
most of the other patients, reinfusion of
the remaining CPB volume, processed
and concentratedwith a special pediatric
small-bowl cell saver, was effective in
establishing or maintaining the target
hemoglobin value of 8 to 10 g/dL.
I have studied your recently pub-
lished article with great interest and ap-
preciate that youwere able to confirm in
a largernumberofpatients, usingacom-
parable perfusion technique (vacuum
assisted venous drainage) and CPB
setup to ours (same oxygenator but not
the arterial filter that we require), that
miniaturized CPB contributes to im-
proved clinical outcomes.5 Establishing
large pools of datawith comparable per-
fusion techniques will help to generate
safety standards for CPB during this
complex operation and assess which
clinical parameters and monitoring
techniques (especially near-infrared
spectroscopy) are useful in the decision
of whether to transfuse. Additionally,
these datawill help to define clearer out-
come parameters because, for example,
serum lactate concentrations might not
be feasible in this regard as a result ofThe Journathe high concentration of lactate in
stored packed red blood cell concen-
trates, whereas the duration of mechan-
ical ventilation and stay in the intensive
care unit might well be acceptable.
I hope that these lines contributed to
a better understanding of our article
and look forward to seeing more data
from your interesting work in the
near future.
Andreas Koster, MDa
Michael Huebler, MDb
Roland Hetzer, MD, PhDb
aDeutsches Herzzentrum Baden
Lahr, Germany
bDeutsches Herzzentrum Berlin
Berlin, Germany
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